Literature DB >> 16501284

Fasting triglyceride is a significant risk factor for coronary artery disease in middle-aged Japanese men.

Hiroki Satoh1, Tetsuo Nishino, Kazuo Tomita, Hiroyuki Tsutsui.   

Abstract

BACKGROUND: It has been well established that dyslipidemia is a significant risk factor for coronary artery disease (CAD), however, the association between fasting triglyceride (TG) and the occurrence of CAD is controversial. The objective of this study was to elucidate the relationship between fasting TG and CAD in middle-aged Japanese men. METHODS AND
RESULTS: A cohort study of 6,966 middle-aged Japanese men (mean +/- SD: 46.6+/-5.2 years) with a 10-year follow-up period was conducted to identify risk factors for the occurrence of CAD. One hundred and eleven cases of CAD were identified during the follow up. The Cox proportional hazard model was used to identify the independent risk factors for CAD. Adjustment was made for variables including age, body mass index, smoking habit, alcohol intake, duration of sleeping, systolic blood pressure, uric acid, total cholesterol, high-density lipoprotein cholesterol, fasting plasma glucose, and TG. Fasting TG was identified as an independent risk factor for CAD. The adjusted hazard ratio of TG for CAD was 3.07 (95% confidence interval: 1.01-9.35, p<0.05). Additionally, a serum TG concentration level greater than 78 mg/dl was a significant risk for CAD.
CONCLUSIONS: By using the long term follow-up data of the study of middle-aged Japanese men, fasting TG was identified to be a significant risk factor for CAD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16501284     DOI: 10.1253/circj.70.227

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  14 in total

1.  Association between the MARS rs6782181 polymorphism and serum lipid levels.

Authors:  Jian Wu; Rui-Xing Yin; Tao Guo; Quan-Zhen Lin; Guang-Yuan Shi; Jia-Qi Sun; Shao-Wen Shen; Yi-Ming Wang; Hui Li; Jin-Zhen Wu
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

3.  Effects of Hedan Tablet () on lipid profile, proprotein convertase subtilisin/kexin type 9 and high-density lipoprotein subfractions in patients with hyperlipidemia: A primary study.

Authors:  Rui-Xia Xu; Na-Qiong Wu; Sha Li; Yan Zhang; Xiao-Lin Li; Yuan-Lin Guo; Cheng-Gang Zhu; Geng Liu; Qian Dong; Jian-Jun Li
Journal:  Chin J Integr Med       Date:  2015-05-13       Impact factor: 1.978

4.  Comparison between the triglycerides standardization of routine methods used in Japan and the chromotropic acid reference measurement procedure used by the CDC Lipid Standardization Programme.

Authors:  Masakazu Nakamura; Hiroyasu Iso; Akihiko Kitamura; Hironori Imano; Hiroyuki Noda; Masahiko Kiyama; Shinichi Sato; Kazumasa Yamagishi; Kunihiro Nishimura; Michikazu Nakai; Hubert W Vesper; Tamio Teramoto; Yoshihiro Miyamoto
Journal:  Ann Clin Biochem       Date:  2016-09-28       Impact factor: 2.057

5.  Efficacy and safety of ezetimibe for Japanese patients with dyslipidaemia: The ESSENTIAL Study.

Authors:  Yasunori Sawayama; Shinji Maeda; Hachiro Ohnishi; Shin Hayashi; Jun Hayashi
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

6.  Association of LIPC -250G>A polymorphism and several environmental factors with serum lipid levels in the Guangxi Bai Ku Yao and Han populations.

Authors:  Li Meng; Yin Ruixing; Li Yiyang; Long Xingjiang; Li Kela; Liu Wanying; Zhang Lin; Lin Weixiong; Yang Dezhai; Pan Shangling
Journal:  Lipids Health Dis       Date:  2010-03-11       Impact factor: 3.876

7.  Necrotic core thickness and positive arterial remodeling index: emergent biomechanical factors for evaluating the risk of plaque rupture.

Authors:  Jacques Ohayon; Gérard Finet; Ahmed M Gharib; Daniel A Herzka; Philippe Tracqui; Julie Heroux; Gilles Rioufol; Melanie S Kotys; Abdalla Elagha; Roderic I Pettigrew
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-27       Impact factor: 4.733

8.  Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels.

Authors:  Yin Ruixing; Li Yiyang; Li Meng; Li Kela; Long Xingjiang; Zhang Lin; Liu Wanying; Wu Jinzhen; Yang Dezhai; Lin Weixiong
Journal:  Lipids Health Dis       Date:  2010-08-17       Impact factor: 3.876

9.  Association of the LIPG 584C > T polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations.

Authors:  Wan-Ying Liu; Rui-Xing Yin; Lin Zhang; Xiao-Li Cao; Lin Miao; Dong-Feng Wu; Lynn Htet Htet Aung; Xi-Jiang Hu; Wei-Xiong Lin; De-Zhai Yang
Journal:  Lipids Health Dis       Date:  2010-10-06       Impact factor: 3.876

10.  Low density lipoprotein receptor gene Ava II polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations.

Authors:  Xing-Jiang Long; Rui-Xing Yin; Ke-La Li; Wan-Ying Liu; Lin Zhang; Xiao-Li Cao; Lin Miao; Dong-Feng Wu; Lynn Htet Htet Aung; Xi-Jiang Hu
Journal:  Lipids Health Dis       Date:  2011-02-23       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.